Preferential Initiation of Long-Acting Injectable Versus Oral HIV Pre-Exposure Prophylaxis Among Women Who Inject Drugs.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 39347705.
- Also identified by DOI 10.1093/cid/ciae450 and PMC identifier 11912968.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Fifty-five of 62 women who inject drugs (WWID) selected long-acting cabotegravir (CAB-LA) over oral PrEP, and 51/55 received a first injection. More recent injection drug use and number of sexual partners were associated with selecting CAB-LA (P < .05). Findings provide preliminary evidence of a strong preference for longer-acting products among WWID.
Medical subject headings
- HIV Infections
- Pre-Exposure Prophylaxis
- Substance Abuse, Intravenous
- Anti-HIV Agents
- Pyridones